Search

Your search keyword '"Wayne G. Shreffler"' showing total 248 results

Search Constraints

Start Over You searched for: Author "Wayne G. Shreffler" Remove constraint Author: "Wayne G. Shreffler"
248 results on '"Wayne G. Shreffler"'

Search Results

1. Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination

2. Longitudinal disease-associated gut microbiome differences in infants with food protein-induced allergic proctocolitis

3. Factors influencing age of common allergen introduction in early childhood

4. Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy

5. In vivo optical endomicroscopy: two decades of translational research towards next generation diagnosis of eosinophilic esophagitis

6. Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells

7. Dogmas, challenges, and promises in phase III allergen immunotherapy studies

8. Identification of antigen-specific TCR sequences based on biological and statistical enrichment in unselected individuals

10. Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)

14. Aptamer based point of care diagnostic for the detection of food allergens

17. In vivo optical endomicroscopy: two decades of translational research towards next generation diagnosis of eosinophilic esophagitis

18. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results

19. Pathophysiology of immunoglobulin E‐mediated food allergy

20. Consensus report from the Food Allergy Research & Education (FARE) 2019 Oral Immunotherapy for Food Allergy Summit

21. Sialylation of immunoglobulin E is a determinant of allergic pathogenicity

22. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials

23. Clonally expanded, GPR15-expressing pathogenic effector T H 2 cells are associated with eosinophilic esophagitis

24. Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells

25. Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

26. Identification of antigen-specific TCR sequences based on biological and statistical enrichment in unselected individuals

28. Reply

29. TCR sequencing paired with massively parallel 3′ RNA-seq reveals clonotypic T cell signatures

30. Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens

31. Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergen

32. Novel vaccines: Technology and development

33. Current and Future Treatment of Peanut Allergy

34. Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells

35. Clonally expanded, GPR15-expressing pathogenic effector T

36. Age and eczema severity, but not family history, are major risk factors for peanut allergy in infancy

37. Gastrointestinal immunopathology of food protein-induced enterocolitis syndrome and other non-immunoglobulin E-mediated food allergic diseases

38. Increased IgE-Mediated Food Allergy With Food Protein-Induced Allergic Proctocolitis

39. Identification of antigen-specific TCR sequences using a strategy based on biological and statistical enrichment in unselected subjects

40. Oral food challenge outcomes in children under 3 years of age

42. Expansion of the CD4+ effector T-cell repertoire characterizes peanut-allergic patients with heightened clinical sensitivity

43. AR101 Oral Immunotherapy for Peanut Allergy

44. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies

45. Physician-diagnosed eczema is an independent risk factor for incident mouse skin test sensitization in adults

46. Integrin αM activation and upregulation on esophageal eosinophils and periostin-mediated eosinophil survival in eosinophilic esophagitis

47. Peanut protein acts as a TH2 adjuvant by inducing RALDH2 in human antigen-presenting cells

48. Data-driven programmatic approach to analysis of basophil activation tests

49. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy

50. Recovery of Paired T Cell Receptors from Single-cell Seq-Well Libraries

Catalog

Books, media, physical & digital resources